AGP Executive Report
Last update: 8 hours agoAntimicrobial Resistance Oversight: Gaelic Laboratories earned BSI Kitemark Certification for minimised risk of AMR, aligning its antibiotic manufacturing with a new industry standard effective in 2026. Diabetes Care Signals: New ADA data highlight persistent gaps in DKA recognition, with early symptoms often mistaken for common illnesses and leading to costly hospitalizations. Obesity Drug Pipeline: Petrelintide (once-weekly) showed sustained weight loss with tolerability that appears better on nausea than GLP-1s in a phase 2 ZUPREME-1 readout. Workforce & Tech: NHS England is rolling out Microsoft 365 Copilot to 505,000 staff, aiming to cut admin time and free clinicians for patient care. Clinical Trial Access: A survey of metastatic breast cancer patients and physicians finds racial and ethnic minorities face distinct barriers to clinical trial participation, pointing to actionable fixes. Global Health Workforce: Kerala’s CM asked India’s Centre to intervene after Dubai’s Iranian Hospital closure left many Indian healthcare workers facing visa and job uncertainty. Diabetes Tech Updates: Insulet discussed Omnipod 5 improvements aimed at boosting automated mode time and tightening glucose control.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.